### Comment:
Well, those two cases are by far the most needy as their death rates are high. But the FDA never told PTLA that they needed this restriction. In fact, that was an indication I thought the FDA may put on AndexXa, and I was glad they ended up not doing so. But now we see that PTLA effectively given themselves that restriction and then some more on top.

### REPLY:
Do you think PTLA may have been anticipating that restriction and prepared accordingly?

### END.